Ąžuolyno vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 636,391 | 708,456 | 802,964 | 850,354 | 1,009,361 | 1,280,359 | 1,735,429 | 1,326,598 |
| Profit before tax | 11,487 | 28,034 | 31,381 | -888 | 37,731 | 29,016 | 83,165 | 36,781 |
| Net profit | 10,720 | 24,088 | 24,787 | -1,410 | 30,088 | 22,921 | 74,030 | 30,048 |
| Equity | 76,909 | 99,713 | 124,500 | 123,090 | 153,178 | 176,099 | 250,129 | 280,177 |
| Liabilities | 96,309 | 75,312 | 96,396 | 86,967 | 118,059 | 209,061 | 124,315 | 84,286 |
| Non-current assets | 57,899 | 48,733 | 41,273 | 39,661 | 37,945 | 30,974 | 148,411 | 184,408 |
| Current assets | 119,583 | 128,470 | 180,274 | 169,619 | 231,557 | 352,325 | 224,763 | 178,476 |
| Total assets | 177,482 | 177,203 | 221,547 | 209,280 | 269,502 | 383,299 | 373,174 | 362,884 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 75,698 | 86,513 | 90,328 |
| Social insurance contributions | - | - | - | - | - | 66,956 | 73,725 | 79,880 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.9% | +11.3% | +13.3% | +5.9% | +18.7% | +26.8% | +35.5% | -23.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.0% | 13.6% | 11.2% | -0.7% | 11.2% | 6.0% | 19.8% | 8.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 13.9% | 24.2% | 19.9% | -1.1% | 19.6% | 13.0% | 29.6% | 10.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.7% | 3.4% | 3.1% | -0.2% | 3.0% | 1.8% | 4.3% | 2.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.8% | 4.0% | 3.9% | -0.1% | 3.7% | 2.3% | 4.8% | 2.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 0.8 | 0.8 | 0.7 | 0.8 | 1.2 | 0.5 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 37,805 | 44,279 | 55,697 | 51,537 | 58,232 | 77,208 | 101,093 | 83,785 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ąžuolyno vaistinė - Social security debts
The company had no debts to Sodra
Ąžuolyno vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ažuolyno vaistine, UAB (code 233893760) is a private limited liability company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €1.33M and net profit of €30.0K, with a profit margin of 2.3%. Revenue declined by 23.6% year on year from 2024, when sales reached €1.74M and net profit was €74.0K. Even so, 2025 revenue remained 3.6% above the 2023 level of €1.28M, while profit also improved versus 2023’s €22.9K. The balance sheet remained solid, with total assets of €362.9K, equity of €280.2K and liabilities of €84.3K. Equity accounted for 77.2% of assets, and the debt-to-equity ratio was 0.30. Asset turnover was 3.66x, indicating efficient use of the asset base. Return on equity stood at 10.7% and return on assets at 8.3%. Revenue per employee was €88.4K and profit per employee €2.0K, showing moderate operating productivity in 2025.